FDA Inspection 785515 — Palo Alto Medical Foundation Reproductive Endocrinology and Infertility
The FDA completed an inspection of Palo Alto Medical Foundation Reproductive Endocrinology and Infertility on June 7, 2012 in San Jose, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 7, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Jose, CA (United States)